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Abstract
Background: Hypoxia plays a critical role in various cellular mechanisms, including proliferation and differentiation
of neural stem and progenitor cells. In the present study, we explored the impact of lowered oxygen on the
differentiation potential of human neural progenitor cells, and the role of erythropoietin in the differentiation
process.
Results: In this study we demonstrate that differentiation of human fetal neural progenitor cells under hypoxic
conditions results in an increased neurogenesis. In addition, expansion and proliferation under lowered oxygen
conditions also increased neuronal differentiation, although proliferation rates were not altered compared to
normoxic conditions. Erythropoietin partially mimicked these hypoxic effects, as shown by an increase of the
metabolic activity during differentiation and protection of differentiated cells from apoptosis.
Conclusion: These results provide evidence that hypoxia promotes the differentiation of human fetal neural
progenitor cells, and identifies the involvement of erythropoietin during differentiation as well as different cellular
mechanisms underlying the induction of differentiation mediated by lowered oxygen levels.
Background
Studies of neural stem and progenitor cells play a very
important role to understand the mechanisms of differ-
entiation of the cells into lineage specific cells like neu-
rons and astroglia [1]. In recent years, a high number of
protocols have been established for the induction of dif-
ferentiation whereat the cells are generally cultured with
an environmental oxygen level of 20%. But within the
brain, oxygen levels are in a much lower range, and vary
depending on the brain region, from 1% to 5% oxygen
[2]. Therefore within the last few years more attention
has been given to micro-environmental oxygen levels for
optimized culturing of specific cell types, and for study-
ing the influences of hypoxia and its underlying cellular
mechanisms on growth and differentiation of stem cells
[3]. Hypoxia-driven effects on regulating of stem/
progenitor cell proliferation and differentiation have
been shown in a number of in vitro systems, such as rat
mesencephalic cell cultures, where hypoxia promoted
neuronal differentiation [4] and hypoxia-inducible factor
1( H I F - 1 )a overexpression lead to similar results as
hypoxia [3]. Contrary to these previously mentioned stu-
dies in primary mouse neural stem cells, cell death was
increased even though proliferation and differentiation
were improved [5]. Murine neural progenitor cells
(NPCs) that were exposed to hypoxia prior to engraft-
ment into a rat brain displayed a better survival than
those without hypoxic preconditioning [6]. Studer et al.
[7] reported an increased number of differentiated neu-
ronal cells and showed trophic and proliferative effects
of lowered oxygen levels on rat neural precursors.
Accordingly, in vivo, global and focal ischemia increases
the proliferation and neuronal differentiation of neural
stem cells in the sub-ventricular zone [8] and in the
sub-granular zone of the dentate gyrus [9,10]. HIF-1a is
one of the major key factors involved in the response to
hypoxia and mediates a variety of cellular responses to
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and induces several cellular responses such as the acti-
vation of numerous target genes e.g. erythropoietin
(EPO), glycolytic enzymes, BMP, Notch and prosurvival
genes [11,12] which are described to be involved in the
regulation of the neuronal progenitor production with
an increased neurogenesis as a part of an intrinsic
hypoxia response in mice [7,13]. In our study we were
interested in the effect of hypoxia on the neuronal dif-
ferentiation of human NPCs. Furthermore as EPO sig-
naling is hypoxia-inducible, we tested whether or not
EPO can mimic the effects of hypoxia under normoxic
conditions. Therefore we investigated the differentiation
potential of human NPCs expanded and differentiated
in different oxygen concentrations and the involvement
of EPO in this differentiation process. As EPO is known
to mimic the effects of hypoxia [7] our main objective
was to demonstrate the differential effects of EPO in
normoxic conditions and to illustrate that EPO causes
subtle changes, but does not completely mimic hypoxia
as suggested by major publications [12,13]. Moreover,
we demonstrated a complex network of reactions of
human NPC towards hypoxia and propose a mechanism
of action within this model.
Results
In our study we used the human immortalized neural pro-
genitor cell line ReNcell VM (Millipore, USA). This cell
line possesses the potential to differentiate into functional
neuronal cells, expressing markers like bIII-tubulin and
tyrosine hydroxylase. [14,15]. Furthermore the cell line is
characterised by a fast proliferation [16] and a rapid onset
of differentiation upon the withdrawl of growth factors
[14-16]. Taken together, this cell line provides an appro-
priate model to study the influence of environmental con-
ditions and factors as hypoxia or EPO, respectively.
Stabilization of HIF-1a and EpoR expression levels in
hNPCs
The induction of HIF-1a, a key molecule of hypoxia, is a
well characterized cellular response to lowered oxygen.
Therefore HIF-1a expression in hNPCs cultured at 3%
oxygen over a time course of 1 h, 3 h, 1 d, 2 d, 3 d and
4 d of differentiation was measured using western blot
analysis (Figure 1). EPO-treatment did not influence the
expression levels of the protein. Although an early up-
regulation of HIF-1a could not be quantified, the consis-
tent expression of HIF-1a demonstrated that the system
is HIF-1a sensitive. Western blot analysis of the EpoR
were performed with proliferating as well as EPO-treated
cells differentiated for 3 days (Figure 2A). The quantifica-
tion of the data showed that the signal intensity is identi-
cal in all conditions tested, with no significant differences
in the EpoR expression levels (Figure 2B), indicating that
any effect of EPO would not be mediated by an upregula-
tion of the EpoR, but by EPO itself.
Influence of low oxygen and EPO on the proliferation
rate of hNPCs
To determine the effect of hypoxia on the proliferation,
hNPCs were expanded either at 20% or 3% O2.I na d d i -
tion, EPO was added to proliferating cells at different
concentrations and cell samples were collected every 24
h to verify the number of cells (Figure 3). At an oxygen
Figure 1 Regulation of HIF-1a under hypoxic conditions. HIF-1a
expression at 3% O2 was determined after 1 h, 3 h, 1 d, 2 d, 3 d
and 4 d using western blot analysis. The cells were differentiated
under hypoxia up to 4 days. Application of 10 IU/ml EPO is
indicated by (+). Untreated conditions are indicated by (-). GAPDH
was used as loading control. “Prol” is indicating proliferating cells,
representing time point zero of differentiation.
Figure 2 Expression of Erythropoietin-receptor. (A) Western blot
analysis of EpoR expression levels of hNPC cell lysates at 20% O2
(black bars) and 3% O2 (white bars) in proliferating and 3 days
differentiating cells. (B) Quantification of the western blot data. No
significant change of the signal intensity was detected; neither
between proliferating and differentiating cells nor in EPO-treated
cells (mean ± SEM).
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Page 2 of 13level of 20%, EPO did not enhance cell proliferation of
hNPCs compared to control cells (Figure 3A). Consis-
tently, EPO did not change the proliferation levels of
hNPCs at 3% oxygen (Figure 3B). To investigate the
effect of hypoxia on the proliferation of hNPCs,
untreated cells from both conditions were compared
and the number of cells/ml was determined. The prolif-
eration curves showed very similar results with no
increase of the proliferation rate under hypoxic condi-
tions (Figure 3C). The comparison of the doubling times
Figure 3 Proliferation of hNPCs. Effects of high and low oxygen concentration on the proliferation of hNPCs. Cells were treated with different
EPO concentrations up to 4 d. Number of cells/ml was determined at 20% oxygen (A) and 3% oxygen (B). Comparing untreated cells (C),
hypoxia had no impact on the proliferation rate within 4 d. The doubling times are not different between both oxygen concentrations and EPO
did not influence the proliferation of cells at different concentrations (E). As control for a positive EPO-response, HCD-57 cells were used (D).
Data are presented as mean ± SEM, n = 3-11 in triplicates.
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Page 3 of 13of treated and untreated cells under normoxic and
hypoxic conditions revealed no significant difference
(Figure 3E). Untreated cells cultured at 20% O2 showed a
doubling time of 19.48 ± 1.34 h and cells cultured at 3%
O2 a doubling time of 20.45 ± 1.53 h. In addition, no sig-
nificant difference of doubling times between the two
groups could be detected with EPO treatment: 10 IU/ml:
11.76 ± 2.08 h (20%) versus 15.12 ± 1.94 h (3%); 50 IU/
ml: 17.46 ± 1.78 h (20%) versus 19.28 ± 1.99 h (3%); 100
IU/ml: 18.77 ± 1.57 h (20%) versus 19.69 ± 4.15 h (3%);
300 IU/ml: 26.38 ± 5.86 h (20%) versus 20.57 ± 2.41 h
( 3 % ) .T ov e r i f yt h ea c t i o no fE P O ,H C D - 5 7c e l l s ,a n
EPO-dependent erythroleukemia cell line, were used.
This cell line needs to be cultured with EPO for regular
proliferation and stops proliferation when cultured with-
out EPO. The application of EPO (0.1, 0.2, 0.3 IU/ml)
resulted in a continuous proliferation of the cells, while
the withdrawal of EPO stopped it (Figure 3D).
Increased metabolic activity of NPCs by hypoxia and EPO
treatment
In order to explore whether hypoxia or normoxia itself or
in combination with EPO had effects on the metabolic
activity of differentiating human NPCs, we tested the
ability of mitochondrial dehydrogenases to cleave the
substrate Wst-1, a tetrazolium salt derivative as a mea-
sure of metabolic activity in presence of different concen-
trations of EPO (Figure 4). ReNcell VM cells were
incubated under differentiation conditions for 1 day and
3 days in the presence and absence of EPO, respectively.
During differentiation EPO caused a significant increase
of metabolic activity after 1 day under normoxic condi-
tions from a concentration of 25 IU/ml on and higher
compared to control (Figure 4A). A similar increase of
the metabolic activity was observed at 3% O2, but higher
EPO concentrations were needed for a significant change
of activity (100 IU/ml and higher, Figure 4B). The signifi-
cant increase of the metabolic activity caused by EPO
was not any longer present after 3 d of differentiation in
both conditions - normoxia and hypoxia - as seen in Fig-
ure 4C and 4D. By comparing the control values of both
conditions, one can see a significant increase of the meta-
bolic activity at 3% oxygen at both time points of differ-
entiation, indicating a general influence of low oxygen on
the cell metabolism which lasts for several days during
differentiation (Figure 4E). For comparison the Wst-1
assay at 1 d and 3 d of proliferating cells is shown in Fig-
ure 4F. Consistently, hypoxia increased the metabolic
activity in this condition.
Lowered oxygen promotes neuronal differentiation of
NPCs
Next, we investigated the effect of lowered oxygen on
the neuronal differentiation of human NPCs. After the
withdrawal of growth factors, ReNcell VM cells were
either differentiated at 20% or 3% oxygen for 4 days.
First we asked the question, whether the differences of
the differentiation between 20% O2 and 3% O2 is caused
by changes of the proportions of cells in each cell cycle
phase. Therefore we performed cell cycle measurements
with flow cytometry, using the DNA binding dye propi-
dium iodide. Figure 5 shows the percentage of cells
within the phases of the cell cycle within the first 24 h
of differentiation. After 20 hours, 95% of the cells
reached G1/G0 phase, both in normoxic (Figure 5A) as
well as in hypoxic (Figure 5B) conditions.
To verify neuronal differentiation, the expression of
bIII-tubulin was measured by FACS analysis. For these
experiments we included additional culturing conditions.
First, the cells proliferated at 20% oxygen and were dif-
ferentiated at either 20% or 3% oxygen (Figure 5C). Sec-
ond, the cells were expanded at 3% and differentiated at
20% or 3% oxygen, respectively (Figure 5D). In addition,
EPO was applied at 10 IU/ml and 100 IU/ml with the
onset of differentiation. As shown in Figure 5C, there is
no difference in the percentage of bIII-tubulin positive
(bIII-tub
+) cells between 20% and 3% oxygen and also
n oi n f l u e n c eo fE P Ou n t i ld a y3o fd i f f e r e n t i a t i o n .
At this time point, the maximal number of neurons
appears with an almost twofold increase of the percen-
tage of bIII-tub
+cells under hypoxic conditions with
4.51 ± 0.45% compared to 2.61 ± 0.31%. At day 4 of dif-
ferentiation, the level of positive cells decreases with low
oxygen supply. These results indicate the supportive
effect of lowered oxygen conditions for the differentia-
tion of hNPCs. In order to determine the influence of
hypoxia in detail, we cultured proliferating cells in low
oxygen (3%) followed by a differentiation at 3% and 20%
oxygen. In Figure 5D the percentage of neurons evalu-
ated by bIII-tubulin expression is shown. Cells prolifer-
ated and differentiated at low oxygen levels displayed an
increase of bIII-tub
+cells at day 3 and at day 4 com-
pared to a proliferation of cells at 20% oxygen. Next we
analysed whether EPO influenced neuronal differentia-
tion, but with both concentrations (10 IU/ml and 100
IU/ml) no change in the number of bIII-tub
+cells was
detected. Figure 5E shows a summary of 3 and 4 days
differentiated hNPCs of all conditions tested. At day 3
significant differences of neuronal differentiation have
been found. The number of neurons was significantly
increased up to 4.51 ± 0.45% when differentiated at 3%
oxygen, compared to 2.95 ± 0.25% when differentiated
at 20% O2. In addition, the expansion of cells at low
oxygen increased the number of bIII-tub
+ cells. When
differentiated at 3%, 5.92 ± 1.66% of positive cells have
been detected, when differentiated at 20%, 5.20 ± 0.87%
of positive cells have been found. This indicates that
there seem to be two independent mechanisms of
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Page 4 of 13Figure 4 Metabolic activity of hNPCs. Effect of oxygen tension on the metabolic activity of differentiating hNPCs. Cells differentiated for 24 h
or 72 h either at 20% (A, C, E, black bars) or 3% O2 (B, D, E, white bars). EPO was applied with the onset of differentiation at various
concentrations (10 - 300 IU/ml). Treatment with EPO resulted in a significant increase of the absorbance from 25 IU/ml onwards at 20% O2 (n =
3-7) and 100 IU/ml at 3% O2 (n = 3-6) indicating a higher metabolic activity of cells after one day of differentiation (A, B). Samples treated with
EPO and differentiated for 3 days showed similar absorbance levels at 20% (n = 3-4) and 3% oxygen (n = 3-4), whereas the increase of
absorbance levels after EPO treatment were not any longer significant. Cultivation of untreated cells at low oxygen concentration resulted in a
2.4 fold increase of the absorbance after one day of differentiation and a 1.7 fold increase after 3 days of differentiation (E), indicating a higher
metabolic activity (n = 4-6), compared to controls. (F) includes the metabolic activity of proliferating cells for comparison with differentiated cells
(E). * p < 0.05, **p < 0.01.
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Page 5 of 13Figure 5 Differentiation of hNPCs. Differentiation of hNPCs in normoxic and hypoxic conditions. Cell cycle analysis by FACS did not reveal
differences in the distribution of the proportion of cells in each cell cycle phase differentiated in 20% oxygen (A, n = 2-4 in duplicates) or 3%
oxygen (B, n = 3-4 in duplicates). By measuring bIII-tub
+ cells up to 4 days of differentiation and EPO-treatment, the percentage of neurons was
evaluated in different culture conditions. Proliferation of cells at 20% and differentiation at 20% resulted at day 3 in an increase of bIII-tub
+ cells
compared to day one (C, n = 3-9). Cells proliferated at 3% oxygen and then differentiated at 3% and 20% oxygen showed a higher number of
neurons at day 3 and day 4 (D, n = 3-5), but EPO treatment did not alter the expression levels in any of the tested conditions. (E) shows the
comparison of the different control conditions, in which significant changes in the bIII-tubulin expression pattern occur with different oxygen
levels (n = 3-9). Mean ± SEM, **p < 0.01). Oxygen levels during proliferation and differentiation are indicated in percentage e.g. 20% - 3%
indicates 20% oxygen during proliferation and 3% oxygen during differentiation.
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Page 6 of 13differentiation. First, a differentiation of human progeni-
tor cells in lowered oxygen increases the number of
neurons and in addition, an expansion of cells in low-
ered oxygen influences the differentiation potential of
hNPCs as well, independently of the culturing condi-
tions (20% or 3% O2) during differentiation.
Anti-apoptotic effect of hypoxia and EPO on
differentiated hNPCs
Since differentiation of progenitor cells is associated
with apoptosis and EPO is a well known anti-apoptotic
mediator, we investigated the amount of apoptotic cells
during differentiation in normoxic and hypoxic condi-
tions (Figure 6). Again the cells differentiated up to 4
days and each day samples were taken from cells cul-
tured under normoxic and hypoxic conditions with and
without the application of EPO. In order to estimate the
amount of apoptotic cells in our cell population a
TUNEL staining and consecutive FACS analysis was
performed. Over time we observed a continuously rising
apoptosis starting with 7.78 ± 3.10% that culminated in
32.43 ± 4.26% at day 4 in cells cultivated with normoxic
oxygen levels. During the first three days neither
hypoxia nor EPO affected the apoptosis of the hNPCs.
On day 4 of differentiation we remarkably observed that
both in hypoxia and normoxic EPO-treated cells the
level of apoptotic cells was only half as high as in the
normoxic control (hypoxia 15.82 ± 4.65%, normoxia
10 IU/ml EPO 18.80 ± 2.17%). There was no significant
difference between EPO-treated normoxic cells and cells
differentiated in hypoxia (p = 0.6). Application of EPO
under hypoxia did not lead to an additional effect
Figure 6 Apoptosis in hNPCs. Rate of apoptotic hNPCs during differentiation at 20% O2 (black bars) and 3% O2 (white bars) detected by
TUNEL staining. Up to day 4 of differentiation, the percentage of apoptotic cells is continuously increasing up to 32.43 ± 4.26%, with no
difference between normoxia, hypoxia, EPO-treated and control cells. At day 4 of differentiation, 10 IU/ml EPO did significantly reduce the
number of apoptotic cells (18.80 ± 2.27%)%. The same decrease was observed when culturing the cells under hypoxia (15.82 ± 4.65%, A) (n = 3,
mean ± SEM, *p < 0.05). Western blot analysis of Bcl-2 of hNPCs differentiated and treated with either normoxia, hypoxia or 10 IU/ml EPO over a
time course of 4 days revealed an increase of signal with the onset of differentiation. GAPDH was used as loading control (B).
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measure the expression of the anti-apoptotic protein
Bcl-2 in cells differentiated up to 4 days. In accordance
with the finding of the FACS measurements, an increase
of Bcl-2 over time was observed (Figure 6B).
Discussion
Standard cultivation conditions for cell cultures com-
prise the use of 20% oxygen, nevertheless a number of
studies have described an enhanced proliferation in low-
ered oxygen. Reducing oxygen can have a number of
different effects such as the increase of proliferation as
shown by Zhao et al. [3] and Studer et al. [7] for rat
embryonic mesencephalic cells, or conversely a decrease
of proliferation as described by Chen et al. [17] who
showed that long-term proliferation in hypoxia was not
beneficial for hESC with short splitting intervals. Studer
et al. [7] investigated the proliferation and differentiation
of embryonic mesencephalic rat cells and came to the
conclusion that hypoxia was beneficial for the cells in
culture and that EPO could mimic this effect under nor-
moxic oxygen levels. Recently Santilli et al. [18]
described an increased proliferation though the cell
cycle remained unaffected as well as an increased neuro-
nal differentiation and decreased cell death of human
neural stem cells caused by mild hypoxia. The effects of
lowered oxygen on the proliferation of stem and pro-
genitor cells are not limited to the central nervous sys-
tem [7,19]. More physiological culturing conditions are
also favoured by other cell types like bone marrow stro-
mal cells [20] and mesenchymal cells [21].
As a first step in this study we verified the expression
of HIF-1a (Figure 1) and the EpoR (Figure 2). The sen-
sibility of the hNPCs to hypoxic conditions is indicated
by the expression of HIF-1a (Figure 1). A similar effect
was observed by Zhou and Miller [19], Zhao et al. [3]
and Zhang et al. [4] ranging from 30 minutes to 24
hours after the onset of hypoxia. HIF-1 is activated
under hypoxic conditions in a variety of cell types and
the HIF-1 targeted genes play an important role in
maintaining cellular homeostasis in response to hypoxia
[22-24]. To investigate the EpoR we chose western blot-
ting as the currently available antibodies lead to incon-
clusive results obtained by immunocytochemistry [25].
The EpoR expression level was not altered by culturing
the cells under EPO application or hypoxic conditions,
the latter being in line with the absence of a hypoxic
EPO effect. Even though this is contrary to Theus et al.
[6] where hypoxia led to an increase in the EpoR
expression, Milosevic et al. [26] likewise observed that
hypoxia does not affect EPO signaling. This inconsis-
tency could be due to different culturing conditions or
cell types. The effect of EPO on the metabolic activity
and apoptosis is independent from the regulation of
expression of its receptor since the expression levels are
not altered between different stages of proliferation or
differentiation, as well as EPO treated cells. In summary,
we conclude that the differentiation of the human NPCs
used in this study as a model system is hypoxia-sensitive
and EPO-responsive.
Both hypoxia and EPO have been reported to induce
the proliferation of NPCs [3,5,7], though our own data
support the idea that hypoxia does not change the prolif-
eration rate or doubling times within three days of
expansion (Figure 3). Similar results were obtained by
Chen et al. [17] where lowered oxygen levels did not
prove to be favourable, and by Milosevic et al. [27] who
described a positive effect of hypoxia on the proliferation
only after culturing NPCs for 1 month, but not prior to
that. In addition, EPO did not affect proliferation
although the EpoR could be detected in proliferating cells
and 10 IU/ml EPO seems to lead to an increased prolif-
eration though this effect was not significant compared
to the control. However, higher amounts of EPO could
be saturating and thus lead to no effect, either.
The differentiation of the hNPCs was investigated
under various conditions. First, the metabolic activity of
differentiating hNPCs was monitored with and without
EPO treatment (Figure 4). An effect of EPO was
detected early in 1 day differentiated cells. Remarkably
at 3% oxygen, EPO was required at higher concentra-
tions to produce an equivalent effect. This indicates
that hypoxia acts only in part via the EPO pathway and
that addition of EPO mimics the effect of lowered oxy-
gen. Generally one can say that hypoxia increases the
metabolic activity of hNPCs, which was highest at 1 d
of differentiation, indicating the importance of early dif-
ferentiation processes, as the effect at day 3 was not as
high as at day 1. These data are in accordance with Stu-
der et al. [7] where EPO mimicked the effect of hypoxia
under normoxic conditions in embryonic mice NPCs.
For further investigation of the differentiation, the cell
cycle of the hNPC was analysed under normoxic and
hypoxic conditions (Figure 5). This analysis revealed
that the cells needed around 20 h to enter G1 phase,
and that this time frame is the same under normoxic
and hypoxic conditions. These findings are in line with
data about the cell cycle of murine midbrain NPCs
where the cell cycle, the proliferation and neurosphere
formation was not altered within 4 weeks of cell culture
[27]. Similar results were obtained by Santilli et al. [18]
who likewise demonstrated no effect of hypoxia on the
cell cycle of human NSCs. These results are of major
importance to further interpret the expression levels of
bIII-tubulin as a marker for neuronal differentiation.
In this study EPO did not alter neuronal differentia-
tion in the hNPCs (Figure 5). This is in contrast to rat
and human mesencephalic progenitors where EPO
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explanation for this discrepancy could be the fact that
different model systems have been used. The percentage
of neurons in our study was increased after culturing
the cells under hypoxic conditions. This is in accordance
with Zhang et al. [4] and Studer et al. [7], where hypoxic
culturing conditions also led to a higher yield of neu-
rons. Since the cells enter differentiation at the same
time point under normoxia and hypoxia the higher yield
of neurons is not due to an accelerated cell cycle, lead-
ing to the conclusion that hypoxia induced neuronal dif-
ferentiation in the precursor cells.
An increase in neurogenesis could be obtained by two
different mechanisms - one during proliferation and the
other during differentiation - partially mimicked by EPO.
First, culturing differentiating NPCs under lowered oxygen
increased the number of neurons after 3 days of differentia-
tion. In addition, proliferation of NPCs under hypoxia and
differentiation of those cells under hypoxic or normoxic
conditions raised the same amount of neurons, indicating a
manipulation of the progenitor cell pool during prolifera-
tion. EPO partially mimicked the effect under normoxia
and displayed anti-apoptotic effects under these culturing
conditions (Figure 5E). Therefore we propose two different
mechanisms of differentiation. One deals with the increase
of neuronal cells by hypoxia during differentiation and the
other one displays an increase of the progenitor pool of
cells during proliferation under hypoxia. The two mechan-
isms result in the same effect, namely the increase of neu-
ronal cells and the increase of the overall activity of
differentiated cells. The first mechanism indicates that
hypoxia induces differentiation and the second one indi-
cates that hypoxia increases the pool of differentiating cells
by changing the cell-fate of the progenitor cells. Prolifera-
tion was investigated at 3% O2 and the rate of differentia-
tion did not change when cells were differentiated at 3% as
well. These results demonstrate that 3% oxygen modifies
the differentiation capability of NPCs.
The cell line used in this study showed a maximal
number of neurons of around 6% (Figure 5), which can
be interpreted as a limitation of this study, however
reported levels of neurons in other NPC lines are simi-
lar. Nevertheless, this cell line also possesses advantages
like the very fast differentiation potential and the easy
accessibility, which enabled us to closely monitor
changes in proliferation and differentiation. Therefore,
those cells serve as a model to investigate differentiation
mechanisms which then can be transferred to systems
which allow for an engraftment into the CNS to cure
neurodegenerative diseases like Parkinson’sd i s e a s eo r
stroke.
Concerning apoptotic cells, the number was reduced
by 50% at day 4 of differentiation at 3% oxygen (Fig-
ure 6). This apoptotic effect was not in consensus with
a neuronal cell death, as the number of neurons was not
influenced which leads to the conclusion that the num-
ber of bIII-tub
+ cells at 3 days of differentiation is not
only an outcome of an anti-apoptotic effect. At the
fourth day of differentiation the effect of EPO is anti-
apoptotic, but numbers of neuronal cells are not altered
by EPO and therefore EPO has no neuron-specific anti-
apoptotic effect. We observed an increased apoptosis at
day 4 in the cells that underwent proliferation and dif-
ferentiation at 20% oxygen, however the underlying
mechanism is not clear. Depending on the severity of
hypoxia it can have differential effects on the apoptosis.
On the one hand it was proven to be anti-apoptotic in a
model for hypoxic-preconditioning [6], on the other
hand it can be pro-apoptotic if it is lowered beyond
levels of mild hypoxia [5,18]. In our study, the anti-
apoptotic effect of hypoxia was also indicated by the
expression of the anti-apoptotic protein bcl-2. The wes-
tern blot of bcl-2 revealed an increase between day one
and two of differentiation, followed by a stable expres-
sion level (Figure 6). Shingo et al. [13] showed an
increase of neurons induced by hypoxia. This enhancing
effect was mimicked by EPO, as it promoted the pro-
duction of neuronal progenitors. This is contrary to our
results, as EPO could not manipulate the neuronal-
producing effect of hypoxia, but did mimic other effects
of hypoxia, like the anti-apoptotic effect during differen-
tiation. The percentage of cells rescued by EPO (18.80 ±
2.27%) at 20% oxygen was not significantly different
from the amount of cells rescued by hypoxia (15.82 ±
4.65%) proving that EPO has the potential to imitate
hypoxic effects under normoxia.
Contrary to Studer et al. [7] and Shingo et al. [13],
EPO did not completely mimick the actions of hypoxia
in our study. In this study, a human fetal cell line was
used whereas Studer et al. [7] and Shingo et al. [13]
used mouse embryonic stem cells. This leads to the con-
clusion that either the point in time (fetal vs. embryo-
nic) or the origin (human vs. mouse) can account for
the observed differences. In addition, the application of
human recombinant EPO to murine cells might lead to
different results than in the human system. And finally,
the oxygen concentration can also influence the out-
come as shown by Zhang et al. [4] and Horie et al. [5].
Both tested varying oxygen concentrations ranging from
0 %t o1 0 %a n df o u n d2 %t o3 %o x y g e nt ob em o s t
effective.
For translational and clinical research our findings are
important because we provide further evidence of
increased neurogenesis in hypoxic scenarios. The cell
survival and ideal environmental oxygen after engraft-
ment of hNSC remain yet unclear and our data supports
the thesis that a hypoxic environment, as seen in stroke
or other neurodegenerative diseases, are beneficial for
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evidence that hypoxia could induce neurogenesis during
proliferation and differentiation, thus the engrafted cells
would not have to be used at a certain point in time
during the cell cycle and therefore making the engraft-
ment process easier. Researchers have tried to profit
from EPO as a neuroprotective agent [28] in patients
with stroke [29] but it remains unclear how EPO acted
neuroprotective. There are three main theories of EPO
action in the human brain. The first presumes a better
oxygenation of the brain through an elevation of red
blood cells after EPO application, the second assumes
EPO effects on astrocytes and blood vessels and indir-
ectly affecting neurons and the third theory actually pro-
poses a neuroprotective effect of EPO [28]. We provide
supporting evidence for the last theory, which
encourages the use of EPO in stroke. As EPO mainly
acts in hematopoiesis and can thus cause hematopoietic
side effects, the neuroprotective effect we explored for
hNSCs should be further and directly exploited by deri-
vatives of EPO, which are non-hematopoietic, neuropro-
tective and able to pass the blood brain barrier easily.
Such structural as well as functional variants of EPO
[30] that fulfil these requirements, among them modi-
fied antibody fragments [31] and peptides [32], have
been described recently.
Conclusions
In summary, we provide evidence for an important role
of hypoxia in the differentiation of human NPCs and
the modulatory action of EPO in vitro. Figure 7 outlines
a hypothetical model of the action and interaction of
hypoxia and EPO including the underlying cellular
mechanisms. Hypoxia displays two modes of action.
First, the proliferation and expansion of NPCs under
hypoxic conditions increases neuronal differentiation.
Second, hypoxia displays an anti-apoptotic action effect-
ing the entire cell population thus leading to an
increased survival rate after the induction of differentia-
tion. EPO partially mimicked these hypoxic effects dur-
ing differentiation and in addition, protected the
differentiated cells from apoptosis. In summary, we con-
clude that the presented data support further research
for the treatment of neurodegenerative diseases as EPO
is acting anti-apoptotic in human NPCs. This also
encourages the thesis that EPO can be directly used for
treatment of stroke or neurodegenerative diseases as we
provide evidence for a direct effect of EPO on neuronal
cells.
Methods
Cell culture of NPCs
In this study we used the human fetal neural progenitor
cell line ReNcell VM (Millipore, USA). Cell culture was
carried out as described previously [15,16]. Cells were
cultivated on laminin (Trevigen, Gaithersburg, MD,
USA) coated dishes at 37°C in 5% CO2 in DMEM/F12
media supplemented with Glutamax, B27 media supple-
ment, heparin sodium salt and gentamycine (all Invitro-
gen, Karlsruhe, Germany). Epidermal growth factor
(20 ng/ml; EGF; Roche, Mannheim, Germany) and basic
fibroblast growth factor (10 ng/ml; bFGF; Roche, Man-
nheim, Germany) were added to the media during pro-
liferation. To induce differentiation, growth factors were
removed from the media. For a decreased oxygen level
of 3% an adjustable incubator was used and the oxygen
level was lowered with N2. For application studies,
EryPo (EPO, Janssen-Cilac, Germany) was applied once
in two different concentrations (10 IU/ml and
100 IU/ml) with the induction of differentiation.
The murine EPO-dependent erythroleukemia cell line
HCD-57 was used as positive control for EPO treatment
[ 3 3 ] .T h e s ec e l l sw e r eg r o w ni ns u s p e n s i o ni nR P M I
medium supplemented with 10% FCS and 1% gentamy-
cine and variable concentrations of EPO.
Cell proliferation assay
The performance of the electrical current exclusion
method (CASY counter) was used to investigate the pro-
liferation of ReNcell VM cells. For proliferation studies
ReNcell VM cells were seeded in 48-well plates, and the
media was changed after 24 hours to control or EPO-
containing media for 3 days and subsequently cell-
counts were performed every 24 hours.
Wst-1 assay
Metabolic activity was assessed using the reagent Wst-1
(Roche, Germany). This calorimetric assay measures the
metabolic activity of viable cells based on the cleavage
of the tetrazolium salt Wst-1 into formazan by mito-
chondrial dehydrogenases. Cells were seeded in 96-well
plates and cultured under proliferating conditions and
either tested during proliferation with or without
hypoxia or were further used for differentiation studies.
Subsequently differentiation was induced by withdrawal
of the growth factors and cells were either incubated at
20% O2 or 3% O2 for an additional time period of 24 h
and 72 h. The Wst-1 reagent was added to a final dilu-
tion of 1:10 for 2 h and the formazan produced by the
metabolic activity of the cells was measured at a wave-
length of 450 nm using a plate reader (Tecan, Mainz,
Germany).
FACS analysis
Cell cycle analysis
For cell cycle analysis, proliferating or differentiating
cells were harvested and fixed in ice-cold 70% ethanol
for 1 h at -20°C. Prior to FACS measurement fixed cells
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Munich, Germany) for 30 min at 37°C following incuba-
tion with 50 μg/ml propidium iodide (PI) for 30 min at
37°C. DNA content was measured by flow cytometry
(FACSCalibur, BD Bioscience, San Jose, CA, USA) and
analyzed by using the Cell Quest Pro software (BD
Bioscience). Aggregated cells and debris revealed by for-
ward scattering were filtered out of the data set prior to
analysis. To quantify G1,S ,a n dG 2/M populations, set-
tings for 2N and 4N peaks were defined within each
experiment from the G1/S-cells and applied to all sam-
ples within a given experiment.
Antibody staining of neuronal proteins
For the detection of bIII-tubulin positive cells, cells were
detached, centrifuged at 100g at room temperature,
washed with PBS without Ca
2+ Mg
2+ and fixed with 1%
PFA in PBS for 15 min. Then, cells were resuspended in
washing buffer (PBS + 0.5% BSA + 0.02% Na-azide) and
stored at 4°C in the dark. After centrifugation cells were
resuspended in saponin buffer (PBS + 0.03% Saponin +
0.5% BSA + 0.02% Na-azide) containing diluted mouse
monoclonal FITC-conjugated b-III-tubulin antibody
(1:100; Abcam, Cambridge, UK) and incubated for two
hours at RT. Cells were washed twice with saponin
buffer and resuspended in wash buffer for analysis. Mea-
surement was done using FACSCalibur (BectonDickin-
son, San Jose, USA) in combination with Cell Quest Pro
software.
TUNEL assay and staining
Apoptotic cells during differentiation were detected with
an in situ cell detection kit (Roche).
Detached cells were fixed with 1% PFA/PBS for
15 min at RT. Afterwards cells were centrifuged and
washing buffer was added (0.2% HSA/HBSS). Until
labelling, samples were stored at 4°C. For permeabiliza-
tion and labelling, samples were centrifuged and washed
with PBS followed by an incubation with permeabiliza-
tion solution (0.1% Triton X-100 in 0.1% sodium citrate)
for two minutes on ice. After an additional washing step
with PBS, cells were incubated with TUNEL reaction
Figure 7 Summary of the effects of EPO and hypoxia. Potential mechanisms of neuronal differentiation of hNPCs and the influence of
hypoxia and EPO. Proliferating cells in normoxia and hypoxia possess the same proliferation rate. Proliferation and differentiation of cells under
normoxic conditions leads to an average yield of neurons. However, changing the oxygen tension after proliferation to hypoxia will lead to a
higher yield of neurons. Similar results can be obtained by culturing the cells in hypoxic conditions during proliferation, though a subsequent
change to normoxia or continuing the cell culture in hypoxia leads to no additional advantage for the hNPCs. We conclude that hypoxia can
induce neurogenesis directly during differentiation and also influence the pool of progenitor cells during proliferation. Anti-apoptotic effectso f
hypoxia also play a major role in the neuroprotective properties of hypoxia. This anti-apoptotic effect as well as the increased metabolic activity
can be partially mimicked by EPO.
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cells were treated with DNase I for 10 minutes. As a
negative control a sample treated with labelling solution
was used. Subsequently cells were washed twice with
PBS and a final volume of 250 μlP B Sw a sa d d e d .T h e
samples were measured and analysed with FACS Calibur
and Cell Quest Pro Software.
Western blot analysis
For western blot analysis total cell extracts were pre-
pared. Cells were washed with HBSS, lysed in ice cold
RIPA buffer containing protease and phosphatase inhibi-
tor cocktails (Roche, Mannheim, Germany) and boiled
5 min at 95°C with 5× sample buffer. Protein content of
lysates was determined using the bicinchoninic acid
assay (BCA™, Pierce, Rockford, IL, USA). Samples were
separated by SDS-PAGE with precast gels (4-15%, Bio-
Rad) and subsequently the proteins were transferred to
nitrocellulose membrane (Hybond-ECL, Amersham)
with a semi-dry blotting system (Bio-Rad) as described
[34]. Membranes were blocked with TBST containing
0.1% Tween 20 and 5% milk powder for 1 h at RT fol-
lowed by incubation with primary antibodies (mouse
monoclonal anti-Bcl-2 (C2), 1:500, rabbit polyclonal
anti-EpoR (M20) 1:1000, mouse monoclonal anti-
GAPDH 1:10,000, mouse monoclonal anti-b-actin
(AC-15) 1:10,000, rabbit polyclonal anti-HIF-1a (H-206)
1:500, all Santa Cruz) overnight at 4°C in blocking buf-
fer. Afterwards blots were rinsed 3 times with TBST
(1% Tween, pH 7.6) and incubated with fluorescent dye
labelled secondary antibodies (Alexa Fluor 680 goat
anti-rabbit IgG, Alexa Fluor 800 goat anti-mouse IgG,
Alexa Fluor 800 goat anti-rabbit IgG and Alexa Fluor
680 goat anti-mouse IgG (all 1:10,000, Molecular
Probes, USA). As a molecular weight marker, the pre-
stained peqGOLD marker IV (PEQLAB, Erlangen,
Germany) was used. Visualization and quantification
were performed with Odyssey Infrared Imaging System
(LI-COR Biosciences GmbH, Bad Homburg, Germany).
Immunoblots were scanned at a wavelength of 700 nm
for Alexa Fluor 680-labeled antibodies and at a wave-
length of 800 nm for IRDye 800CW-labeled antibodies,
respectively using Odyssee software version 1.2. Expres-
sion of b-actin or GAPDH were used for normalization.
Values were normalized and thereby relative expression
levels of the target proteins were determined.
Statistical analysis
All results are shown as mean ± SEM of data. Statistical
analysis was performed with the student’s t-test or One-
way ANOVA with Dunnett post-test. p < 0.05 was con-
sidered to indicate statistically significance using Prism5
(GraphPad Prism. Inc., USA).
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